Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation

(2020) Gerhard C. Hildebrandt et al.   BRITISH JOURNAL OF HAEMATOLOGY

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab

(2020) S. Elhadad et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant

(2020) Christopher E. Dandoy et al.   Blood Advances

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation

(2018) Merve Postalcioglu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal

(2018) Ang Li et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy

(2018) Meredith P. Schuh et al.   PEDIATRIC NEPHROLOGY

Drugs Against Rare Diseases: Are The Regulatory Standards Higher?

(2016) J Gobburu et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation

(2016) H. Kozarcanin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs

(2015) Frank J. Sasinowski et al.   Therapeutic Innovation & Regulatory Science

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

(2014) S. Jodele et al.   BLOOD

Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis

(2012) Sepideh Shayani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment

(2012) Sascha Dietrich et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The role of the endothelium in the short-term complications of hematopoietic SCT

(2011) E Carreras et al.   BONE MARROW TRANSPLANTATION

Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury

(2011) W. J. Schwaeble et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation

(2010) Byung-Sik Cho et al.   TRANSPLANTATION

Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot

(2009) Krishana C. Gulla et al.   IMMUNOLOGY